RCS - Intelligent Ultrasnd - Launch of NeedleTrainer 2
02/09/2022 11:09
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220902:nRSB1187Ya&default-theme=true
RNS Number : 1187Y Intelligent Ultrasound Group PLC 02 September 2022
REACH
Intelligent Ultrasound Group plc
("IUG" or the "Company")
Launch of NeedleTrainer 2
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic'
ultrasound company, specialising in artificial intelligence (AI) software and
simulation, announces it has launched an updated version of its 'first in
kind' technology NeedleTrainer™, making ultrasound-guided needle training
even more accessible to medical professionals, through a high performance,
pocket-sized wireless ultrasound machine - GE Healthcare's Vscan™ Air.
NeedleTrainer is a real-time simulation tool, which has been designed to
develop the needle-probe co-ordination skills required for safe ultrasound
guided interventional procedures.
The first of its kind, NeedleTrainer uses a retractable needle, with the
ability to add virtual image overlays to simulate needling non-invasively on a
live participant, using a live ultrasound scan. This enables trainees to
develop hand-eye coordination, optimum positioning, and accuracy in
ultrasound-guided interventional procedures in a simulated clinical
environment without delaying patient care or risking patient safety.
Ten months since the original version launched in the marketplace, and the
platform is already being embraced by regional anesthesia medical education
schools including Health Education and Improvement Wales
(https://www.intelligentultrasound.com/2022/04/25/heiw-invests-in-needletrainer/)
and University College London Hospital
(https://www.intelligentultrasound.com/2022/06/17/uclh-invests-in-needletrainer-and-scannav-anatomy-pnb/)
to expand training opportunities and drive curriculum changes.
In line with IUG's vision to 'unlock ultrasound for everyone', the latest
version of NeedleTrainer
(https://www.intelligentultrasound.com/needletrainer/) makes ultrasound-guided
needling even more accessible to medical professionals. Previously only
available to users with an existing compatible ultrasound system, IUG has now
expanded this offering. The latest generation of NeedleTrainer incorporates a
GE Vscan Air; a wireless, handheld ultrasound probe that makes the system
portable, removes the need to re-purpose a console-based ultrasound machine
for training, while making the platform available to more institutions.
NeedleTrainer is available in two offerings: as a needle training simulator,
applicable to any speciality that performs ultrasound guided needling. For
regional anaesthesia there is also NeedleTrainer Plus, which includes the
needle training simulator, with a built in trainer for peripheral nerve blocks
(PNB) that include AI powered overlay of body structures option for the ten
most common blocks when training on regional anaesthesia.
Once a practitioner is competent, they can then use the standalone ScanNav
Anatomy PNB device in the clinic for real-time AI assistance of
ultrasound-guided regional anesthesia.
Dr Dennis Cochlin, MB BCh FRCR, Consultant in General Ultrasound at the
University Hospital of Wales, Cardiff commented: "This is a great example of
how invasive procedures can be taught in a safe environment. This is
particularly important for the increasing number of practitioners who use
ultrasound to guide procedures, but where ultrasound is not their main
specialty. However, anyone who practices ultrasound guided needling, however
experienced, will welcome this."
Nicholas Sleep, Chief Technology Officer of Intelligent Ultrasound commented:
"Still a 'first in kind' platform, NeedleTrainer 2 is the latest development
in IUG's vision to make ultrasound simpler to use and easier to learn. We're
pleased to extend our partnership with GE Healthcare by incorporating the
Vscan Air into our system, which makes this technology portable and available
to any medical education programme which teaches ultrasound-guided needling.
Centres will be able to adapt to new curriculum requirements, without
impacting clinical hours or patient safety."
GE Healthcare has a century long track record of delivering high impact
healthcare innovations, with more than 30 years in ultrasound. GE was the
first to introduce a pocket-sized color ultrasound to the market; the over
30,000 Vscan units in the pockets of clinicians in 100 countries impacts the
care of 50 million patients worldwide.
To learn more about NeedleTrainer, readers can visit the
(https://www.intelligentultrasound.com/needletrainer/) IUG
(https://www.intelligentultrasound.com/needletrainer/) website
(https://www.intelligentultrasound.com/needletrainer/) .
Intelligent Ultrasound Group plc www. intelligentultrasound.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy Mob: +44 (0)7876 741 001
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to
clinic' ultrasound companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market ('clinic'). Based in Cardiff in
the UK and Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through simulation.
Our main products are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training simulator,
the BodyWorks Eve Point of Care and Emergency Medicine training simulator
with Covid-19 module and the new BabyWorks Neonate and Paediatric training
simulator. To date over 1,400 simulators have been sold to c. 700 medical
institutions around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines smarter and more
accessible using our proprietary ScanNav ultrasound image analysis technology.
Current products on the market utilising this technology are GE
Healthcare's SonoLyst software that is incorporated in their Voluson Expert
22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer
that teaches real-time ultrasound-guided needling and incorporates ScanNav
Anatomy PNB.
www.intelligentultrasound.com (http://www.intelligentultrasound.com/)
NOTE: ScanNav Anatomy PNB is CE approved, but not yet available for sale in
the US or any other territory requiring government approval for this type of
product.
About Reach announcements
This is a Reach announcement. Reach is an investor communication service
aimed at assisting listed and unlisted (including AIM quoted) companies
to distribute media only / non-regulatory news releases into the public
domain. Information required to be notified under the AIM Rules for
Companies, Market Abuse Regulation or other regulation would be disseminated
as an RNS regulatory announcement and not on Reach.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRABLLFBLKLBBBV